AIFA – Italian Medicines Agency: "The use of medicines in Italy – OsMed 2021 Report" Update of 07.29.2022.https://www.aifa.gov.it/documents/20142/1740782/Rapporto-OsMed-2021.pdf

(Accessed July 2024)

Prime Ministerial Decree 01.12.2017: "Definition and updating of the essential levels of assistance, referred to in article 1, paragraph 7, of the legislative decree of December 30 1992, n. 502" Official Gazette General Series, n. 65 of March 18 2017. https://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=58669 (Accessed July 2024)

Ministerial Decree n. 77, 23.05.2022: "Regulation establishing the definition of models and standards for the development of territorial assistance in the National Health Service". https://www.gazzettaufficiale.it/atto/vediMenuHTML?atto.dataPubblicazioneGazzetta=2022-06-22&atto.codiceRedazionale=22G00085&tipoSerie=serie_generale&tipoVigenza=originario

(Accessed July 2024)

Presidency of the Council of Ministers. "Italy tomorrow- National Recovery and Resilience Plan". Online www.italiadomani.gov.it (Accessed July 2024)

Gnjidic D, Johnell K. Clinical implications from drug-drug and drug-disease interactions in older people. Clin Exp Pharmacol Physiol. 2013;40(5):320-325. https://doi.org/10.1111/1440-1681.12081 PMID:23528015 DOI: https://doi.org/10.1111/1440-1681.12081

Ministry of Health: "National Chronicity Plan". Last update 15.09.2016. https://www.salute.gov.it/imgs/C_17_pubblicazioni_2584_allegato.pdf (Accessed July 2024)

Ministry of Health. "Ministerial Recommendation n°17- Failure to reconcile drug therapy can cause serious harm to patients" Last update: December 2014. Online www.salute.gov.it (Accessed July 2024)

Crisafulli S, Poluzzi E, Luunghi C, et al. Deprescribing as a strategy for improving safety of medicines in older people: Clinical and regulatory perspective. Frontiers in Drug Safety and Regulation 2022; 2 https://doi.org/10.3389/fdsfr.2022.1011701. DOI: https://doi.org/10.3389/fdsfr.2022.1011701

Zazzara MB, Cangni A, Cas Da R, et al. Medication use and costs among older adults aged 90 years and older in Italy. Frontiers in Pharmacology 2022; 13 https://doi.org/10.3389/fphar.2022.818875. DOI: https://doi.org/10.3389/fphar.2022.818875

Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279(15):1200-1205. https://doi.org/10.1001/jama.279.15.1200 PMID:9555760 DOI: https://doi.org/10.1001/jama.279.15.1200

Sivagnanam G. Deprescription: the prescription metabolism. J Pharmacol Pharmacother. 2016;7(3):133-137. https://doi.org/10.4103/0976-500X.189680 PMID:27651709 DOI: https://doi.org/10.4103/0976-500X.189680

Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793-807. https://doi.org/10.1007/s40266-013-0106-8 PMID:23912674 DOI: https://doi.org/10.1007/s40266-013-0106-8

Luymes CH, Poortvliet RKE, van Geloven N, et al. Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice - the ECSTATIC study: a cluster randomized non-inferiority trial. BMC Med. 2018;16(1):5. https://doi.org/10.1186/s12916-017-0988-0 PMID:29321031 DOI: https://doi.org/10.1186/s12916-017-0988-0

Mahlknecht A, Wiedermann CJ, Sandri M, et al. Expert-based medication reviews to reduce polypharmacy in older patients in primary care: a northern-Italian cluster-randomized controlled trial. BMC Geriatr. 2021;21(1):659. https://doi.org/10.1186/s12877-021-02612-0 PMID:34814835 DOI: https://doi.org/10.1186/s12877-021-02612-0

Jowett S, Kodabuckus S, Ford GA, et al; OPTiMISE investigators. Cost-effectiveness of antihypertensive deprescribing in primary care: a markov modelling study using data from the OPTiMISE trial. Hypertension. 2022;79(5):1122-1131. https://doi.org/10.1161/HYPERTENSIONAHA.121.18726 PMID:35266409 DOI: https://doi.org/10.1161/HYPERTENSIONAHA.121.18726

Caldeira D. Deprescribing cardiovascular drugs in low-risk patients increases the risk of uncontrolled blood pressure and LDL-cholesterol. BMJ Evid Based Med. 2018;23(6):235-236. https://doi.org/10.1136/bmjebm-2018-110976 PMID:30018072 DOI: https://doi.org/10.1136/bmjebm-2018-110976

Sukumar S, Orkaby AR, Schwartz JB, et al. Polypharmacy in older heart failure patients: a multidisciplinary approach. Curr Heart Fail Rep. 2022;19(5):290-302. https://doi.org/10.1007/s11897-022-00559-w PMID:35723783 DOI: https://doi.org/10.1007/s11897-022-00559-w

Barrons R. Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm. 2004;61(4):380-385. https://doi.org/10.1093/ajhp/61.4.380 PMID:15011766 DOI: https://doi.org/10.1093/ajhp/61.4.380

Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. https://doi.org/10.1016/0021-9681(87)90171-8 PMID:3558716 DOI: https://doi.org/10.1016/0021-9681(87)90171-8

Becker ML, Kallewaard M, Caspers PW, et al. Hospitalizations and emergency department visits due to drug-drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641-651. https://doi.org/10.1002/pds.1351 PMID:17154346 DOI: https://doi.org/10.1002/pds.1351

Radovanovic D, Seifert B, Urban P, et al. AMIS Plus Investigators. Validity of Charlson Comorbidity Index in patients hospitalized with acute coronary syndrome. Insights from the nationwide AMIS Plus registry 2002-2012. Heart. 2014;100(4):288-294. https://doi.org/10.1136/heartjnl-2013-304588 PMID:24186563 DOI: https://doi.org/10.1136/heartjnl-2013-304588

Nota 99 per la Prescrizione di farmaci ad uso inalatorio nei pazienti affetti da Broncopneumopatia Cronica Ostruttiva (BPCO); Agenzia Italiana del Farmaco: Rome, Italy, 2021. https://www.aifa.gov.it/documents/20142/1728122/nota-99.pdf (Accessed July 2024)

Nota 96 per la Prescrizione di farmaci a base di vitamina D; Agenzia Italiana del Farmaco: Rome, Italy, 2021. https://www.aifa.gov.it/documents/20142/1728113/nota-96.pdf (Accessed July 2024)

Rea F, Biffi A, Ronco R, et al. Cardiovascular outcomes and mortality associated with discontinuing statins in older patients receiving polypharmacy. JAMA Netw Open. 2021;4(6):e2113186. https://doi.org/10.1001/jamanetworkopen.2021.13186 PMID:34125221 DOI: https://doi.org/10.1001/jamanetworkopen.2021.13186

Gulliford M, Ravindrarajah R, Hamada S, et al. Inception and deprescribing of statins in people aged over 80 years: cohort study. Age Ageing. 2017;46(6):1001-1005. https://doi.org/10.1093/ageing/afx100 PMID:29088364 DOI: https://doi.org/10.1093/ageing/afx100

Odden MC, et al. The population impact and cost-effectiveness of statins for primary prevention in adults 75 and older in the United States. Ann Intern Med. 2015;162(8):533. https://doi.org/10.7326/M14-1430 PMID:25894023 DOI: https://doi.org/10.7326/M14-1430

Bonnet F, Bénard A, Poulizac P, et al. Discontinuing statins or not in the elderly? Study protocol for a randomized controlled trial. Trials. 2020;21(1):342. https://doi.org/10.1186/s13063-020-04259-5 PMID:32307005 DOI: https://doi.org/10.1186/s13063-020-04259-5

Chadha M, Jain SM, Chawla R, Dharmalingam M, Chaudhury T, Talwalkar PG, Tripathi S, Singh SK, Gutch M, Dasgupta A. Evolution of Guideline Recommendations on Insulin Therapy in Type 2 Diabetes Mellitus Over the Last Two Decades: A Narrative Review. Curr Diabetes Rev. 2023;19(8):e160123212777. doi: 10.2174/1573399819666230116150205. PMID: 36650625; DOI: https://doi.org/10.2174/1573399819666230116150205

Ashkenazi I, Schermann H, Gold A, et al. Is continuation of anti-platelet treatment safe for elective total hip arthroplasty patients? Arch Orthop Trauma Surg. 2020;140(12):2101-2107. https://doi.org/10.1007/s00402-020-03629-7 PMID:33040197 DOI: https://doi.org/10.1007/s00402-020-03629-7

Kaatz S, Mahan CE, Nakhle A, et al. Management of elective surgery and emergent bleeding with direct oral anticoagulants. Curr Cardiol Rep 2017; 19, 124 https://doi.org/10.1007/s11886-017-0930-2. DOI: https://doi.org/10.1007/s11886-017-0930-2

Avery AJ, Bell BG. Rationalizing medications through deprescribing. BMJ. 2019;364:l570. https://doi.org/10.1136/bmj.l570 PMID:30733211 DOI: https://doi.org/10.1136/bmj.l570

Procacci C, Degli Esposti L, Furno C, et al. The economic impact of different blood glucose monitoring systems in the diabetic patient: analysis of real-world data from an Italian local health authority. Ethics Med Public Health. 2023;29:100912. https://doi.org/10.1016/j.jemep.2023.100912 DOI: https://doi.org/10.1016/j.jemep.2023.100912

Karapinar-Çarkit F, Borgsteede SD, Zoer J, et al. Effect of medication reconciliation on medication costs after hospital discharge in relation to hospital pharmacy labor costs. Ann Pharmacother. 2012;46(3):329-338. https://doi.org/10.1345/aph.1Q520 PMID:22395255 DOI: https://doi.org/10.1345/aph.1Q520